Maria Perde-Schrepler
Overview
Explore the profile of Maria Perde-Schrepler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perde-Schrepler M, Brie I, Maniu A
Biomol Biomed
. 2025 Mar;
PMID: 40066763
Sensorineural hearing loss (SNHL) can result from various factors, including ototoxic drugs (such as aminoglycosides and chemotherapeutic agents), prolonged exposure to intense sound, and autoimmune or genetic disorders. In adult...
2.
Dindelegan M, Blebea C, Perde-Schrepler M, Necula V, Maniu A, Pascalau V, et al.
Cureus
. 2024 Oct;
16(10):e71142.
PMID: 39386930
A functional hydrogel containing biopolymer microcarriers loaded with dexamethasone was developed to address the hearing loss that results from cisplatin ototoxicity. The drug delivery platform was tested both in vitro...
3.
Dindelegan M, Pascalau V, Suciu M, Neamtu B, Perde-Schrepler M, Blebea C, et al.
Gels
. 2022 Aug;
8(8).
PMID: 36005084
Dexamethasone is one of the most often used corticosteroid drugs for sensorineural hearing loss treatment, and is used either by intratympanic injection or through systemic delivery. In this study, a...
4.
Blebea C, Ujvary L, Necula V, Dindelegan M, Perde-Schrepler M, Stamate M, et al.
Medicina (Kaunas)
. 2022 Jun;
58(6).
PMID: 35744010
Hearing loss is the most common neurosensory disorder, and with the constant increase in etiological factors, combined with early detection protocols, numbers will continue to rise. Cochlear implantation has become...
5.
Dicu T, Virag P, Brie I, Perde-Schrepler M, Fischer-Fodor E, Victor B, et al.
Int J Radiat Biol
. 2021 Sep;
98(1):18-29.
PMID: 34586971
Background And Purpose: Radon and its radioactive progenies are the most important source of ionizing radiation of natural origin, being classified as a Group 1 carcinogen. The aim of this...
6.
Borlan R, Stoia D, Gaina L, Campu A, Marc G, Perde-Schrepler M, et al.
Molecules
. 2021 Aug;
26(15).
PMID: 34361832
In recent times, researchers have aimed for new strategies to combat cancer by the implementation of nanotechnologies in biomedical applications. This work focuses on developing protein-based nanoparticles loaded with a...
7.
Borlan R, Focsan M, Perde-Schrepler M, Soritau O, Campu A, Gaina L, et al.
Biomater Sci
. 2021 Aug;
9(18):6183-6202.
PMID: 34346411
Among women, ovarian cancer is the fifth most frequent type of cancer, and despite benefiting from current standard treatment plans, 90% of patients relapse in the subsequent 18 months and,...
8.
Cenariu D, Fischer-Fodor E, Tigu A, Bunea A, Virag P, Perde-Schrepler M, et al.
Molecules
. 2021 Jan;
26(2).
PMID: 33440679
The concern for implementing bioactive nutraceuticals in antioxidant-related therapies is of great importance for skin homeostasis in benign or malignant diseases. In order to elucidate some novel insights of (Goji...
9.
Molnar E, Gal E, Gaina L, Cristea C, Fischer-Fodor E, Perde-Schrepler M, et al.
Int J Mol Sci
. 2020 May;
21(9).
PMID: 32365924
We report here the synthetic procedure applied for the preparation of new AB-type and -AB type -halogenophenothiazinyl-phenyl-porphyrin derivatives, their metal core complexation and their peripheral modification using Suzuki-Miyaura cross coupling...
10.
Crisan M, David L, Moldovan B, Vulcu A, Dreve S, Perde-Schrepler M, et al.
J Mater Chem B
. 2020 Apr;
1(25):3152-3158.
PMID: 32260915
The main purpose of the present paper is to emphasize the non-invasive effect of some new prepared nanomaterials on skin diseases (psoriasis) together with the procedures to obtain them. These...